Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduction in Vaccine-Type Human Papillomavirus Prevalence Among Women in the United States, 2009-2012.

The Journal of infectious diseases - 15 Dec 2016

Berenson Abbey B, Laz Tabassum Haque, Rahman Mahbubur

Abstract excerpt

Between 2009 and 2012, the proportion of young women in the United States completing the human papillomavirus (HPV) vaccine doubled. To understand how quickly this increased uptake is affecting women in the United States, we evaluated the prevalence of vaccine-type (VT) HPV strains among young women in national data sets from 2009-2010 and 2011-2012. Among 18-26-year-old women, the prevalence of VT HPV decreased...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adolescent
Share to Cross-Sectional Studies
Share to Papillomaviridae

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Papillomavirus Infections

Share to Papillomavirus Vaccines

Share to Prevalence

Share to United States

Share to Young Adult

Source

Identifiers

PMID: 27821406
DOI: 10.1093/infdis/jiw515

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduction in Vaccine-Type Human Papillomavirus Prevalence Among Women in the United States, 2009-2012.PMID 27821406Read ↗

Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.Semantic proximity Read ↗

Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013.Semantic proximity Read ↗

Human papillomavirus genotype-specific prevalence and infection risks: a 10-year population-based study from the United StatesSemantic proximity Read ↗

Postvaccination prevalence of vaccine-Human Papillomavirus (vHPV) genotypes among the target population: A systematic review and meta-analysis.Semantic proximity Read ↗

Human Papillomavirus: An Old New HistorySemantic proximity Read ↗

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes.Semantic proximity Read ↗

Human papillomavirus vaccination: the population impactSemantic proximity Read ↗

Trend of HPV Molecular Epidemiology in the Post-Vaccine Era: A 10-Year Study.Semantic proximity Read ↗

Impact of HPV vaccination with Gardasil® in Switzerland.Semantic proximity Read ↗

Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.Semantic proximity Read ↗

Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.Semantic proximity Read ↗

Time trend analysis of cervical high-risk human papillomavirus (HPV) in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil: the rise of non-16/18 HPV.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.